Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Harvard Business School
Daiichi Sankyo
Healthtrust
Fuji
Teva
Chinese Patent Office
Baxter
Johnson and Johnson

Generated: June 18, 2018

DrugPatentWatch Database Preview

Halobetasol propionate - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for halobetasol propionate and what is the scope of halobetasol propionate patent protection?

Halobetasol propionate
is the generic ingredient in two branded drugs marketed by Theraps Inc, Fougera Pharms, G And W Labs, Perrigo Israel, Taro, Sun Pharm Inds Inc, Sun Pharm Industries, G And W Labs Inc, and Teligent Pharma Inc, and is included in fourteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Halobetasol propionate has sixteen patent family members in fifteen countries.

There are nine drug master file entries for halobetasol propionate. Ten suppliers are listed for this compound.
Pharmacology for halobetasol propionate
Synonyms for halobetasol propionate
(1R,8S,13S,14R)-14-(2-chloroacetyl)-1,8-difluoro-17-hydroxy-2,13,15-trimethyl-5-oxotetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-3,6-dien-14-yl propanoate
(1R,8S,13S,14R)-14-(2-CHLOROACETYL)-1,8-DIFLUORO-17-HYDROXY-2,13,15-TRIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-14-YL PROPANOATE
(6|A,11|A,16|A)-21-Chloro-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione
(6|A,11|A,16|A)-21-Chloro-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione; Miracorten; Ulobetasol propionate; Ultravate
(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate
[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
[(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
[17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
21-Chloro-6alpha,9-difluoro-11beta,17-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate
6 alpha-fluoroclobetasol 17-propionate
6-fluoroclobetasol 17-propionate
66852-54-8
852H548
91A0K1TY3Z
AB01566925_01
AB2000750
AC1L2JJ6
AC1NBUQD
AC1OCF43
AKOS025310143
AN-14228
API0002882
AS-14150
BDSYKGHYMJNPAB-LICBFIPMSA-N
BMY 30056
BMY-30056
C25H31ClF2O5
CAS-66852-54-8
CGP 14 458
CGP 14458
CGP-14,458
CGP-14458
CHEBI:135782
CHEMBL1200908
CHEMBL1876307
CS-4305
CTK8G0126
D00XPC
D04409
DR002999
DSSTox_CID_26636
DSSTox_GSID_46636
DSSTox_RID_81782
DTXSID6046636
FT-0630768
Halobetasol (propionate)
Halobetasol propionate (USAN)
Halobetasol propionate [USAN:USP]
Halobetasol propionate [USAN]
Halobetasol(propionate)
Halobetasolpropionate
HY-B0878
K097
KS-00001F9L
LS-118431
Miracorten
MolPort-006-167-587
MolPort-023-278-129
NCGC00167451-01
PL066286
Pregna-1,4-diene-3,20-dione, 21-chloro-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (6alpha,11beta,16beta)-
Pregna-1,4-diene-3,20-dione, 21-chloro-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-,(6-alpha,11-beta,16-beta)-
s4089
SC-18329
SCHEMBL1650038
SCHEMBL33858
SR-01000942239
SR-01000942239-1
Tox21_112455
Ulobetasol (Halobetasol)Propionate
Ulobetasol cream
Ulobetasol propionate
Ultravate
Ultravate (TN)
UNII-91A0K1TY3Z
ZINC3920028

US Patents and Regulatory Information for halobetasol propionate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Industries ULTRAVATE halobetasol propionate LOTION;TOPICAL 208183-001 Nov 6, 2015 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
G And W Labs HALOBETASOL PROPIONATE halobetasol propionate CREAM;TOPICAL 078162-001 Apr 24, 2007 AB RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Theraps Inc HALOBETASOL PROPIONATE halobetasol propionate AEROSOL, FOAM;TOPICAL 210566-001 May 24, 2018 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharm Inds Inc ULTRAVATE halobetasol propionate CREAM;TOPICAL 019967-001 Dec 27, 1990 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for halobetasol propionate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sun Pharm Inds Inc ULTRAVATE halobetasol propionate CREAM;TOPICAL 019967-001 Dec 27, 1990 ➤ Try a Free Trial ➤ Try a Free Trial
Sun Pharm Inds Inc ULTRAVATE halobetasol propionate OINTMENT;TOPICAL 019968-001 Dec 17, 1990 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Cantor Fitzgerald
Johnson and Johnson
Argus Health
Farmers Insurance
US Army
Express Scripts
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.